Name | 7H-xanthine |
---|---|
Synonyms |
UREOUS ACID
Xan xanthicoxide Dioxopurine 9H-xanthine 2,5-DIFLUOROTHIOBENZAMIDE usafcb-17 Xanthine 9H-Purine-2,6(1H,3H)-dione Purine-2,6(1H,3H)-dione Xanthin ISOXANTHINE 2,6-Dihydroxypurine MFCD00078453 3,7-dihydropurine-2,6-dione Xanthione EINECS 200-718-6 3,7-dihydro-1H-purine-2,6-dione 1H-Purine-2,6-dione, 3,7-dihydro- 3,7-dihydro-purine-2,6-dione 2,6(1H,3H)-Purinedione |
Description | Xanthine is a purine base found in most human body tissues and fluids and in other organisms. |
---|---|
Related Catalog | |
Target |
Human Endogenous Metabolite |
In Vitro | A number of stimulants are derived from Xanthine including caffeine and theobromine. Xanthine is a product on the pathway of purine degradation. Xanthine is subsequently converted to uric acid by the action of the Xanthine oxidase enzyme. |
Density | 1.6±0.1 g/cm3 |
---|---|
Boiling Point | 834.9ºC at 760 mmHg |
Melting Point | 300 °C |
Molecular Formula | C5H4N4O2 |
Molecular Weight | 152.111 |
Flash Point | 458.7ºC |
Exact Mass | 152.033432 |
PSA | 94.40000 |
LogP | -0.81 |
Index of Refraction | 1.636 |
Storage condition | Store at RT. |
Water Solubility | NH4OH: freely soluble |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
MUTATION DATA
|
Symbol |
GHS07 |
---|---|
Signal Word | Warning |
Hazard Statements | H317-H319 |
Precautionary Statements | P280-P305 + P351 + P338 |
Personal Protective Equipment | dust mask type N95 (US);Eyeshields;Faceshields;Gloves |
Hazard Codes | Xi:Irritant; |
Risk Phrases | R36;R43 |
Safety Phrases | S36/37 |
RIDADR | NONH for all modes of transport |
WGK Germany | 3 |
RTECS | ZD7700000 |
HS Code | 2933990090 |
Precursor 10 | |
---|---|
DownStream 10 | |
HS Code | 2933990090 |
---|---|
Summary | 2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |